Staphylococcus aureus Endocarditis in Drug Users vs Nonaddicts
Author Information
Author(s): Eeva Ruotsalainen, Kari Sammalkorpi, Janne Laine, Kaisa Huotari, Seppo Sarna, Ville Valtonen, Asko Järvinen
Primary Institution: Helsinki University Central Hospital
Hypothesis
What are the differences in clinical manifestations and outcomes of Staphylococcus aureus endocarditis between injection drug users and nonaddicts?
Conclusion
Injection drug users with Staphylococcus aureus endocarditis had lower mortality rates compared to nonaddicts despite similar complication rates.
Supporting Evidence
- Endocarditis was more common in drug users (46%) than in nonaddicts (14%).
- IDUs had less fatal underlying diseases (0% vs 37%).
- Mortality at 3 months was lower among IDUs (10%) compared to nonaddicts (39%).
- Right-sided endocarditis was more common in IDUs (60%) than left-sided in nonaddicts (93%).
Takeaway
This study found that people who use drugs and get heart infections have a better chance of surviving than those who don't use drugs, even though both groups have similar health problems.
Methodology
A prospective study followed 430 patients with Staphylococcus aureus bacteremia, identifying 74 with endocarditis based on modified Duke criteria.
Potential Biases
Potential bias due to the exclusion of patients with certain conditions and the focus on a specific population.
Limitations
The study only included methicillin-sensitive Staphylococcus aureus strains, which may limit the generalizability of the findings to regions with high rates of methicillin-resistant strains.
Participant Demographics
20 injection drug users and 54 nonaddicts, with IDUs being significantly younger (mean age 27) compared to nonaddicts (mean age 65).
Statistical Information
P-Value
p<0.001
Confidence Interval
95% CI, 2.65–9.91
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website